Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-fluorouracil therapeutic drug monitoring in Chinese colorectal cancer patients
ChiCTR-IPR-15006431Phase 2Recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of fluorouracil in colorectal cancer (CRC) (2 arms), sponsored by Shanghai General Hospital. Primary endpoints: Objective response rate and Blood concentration of 5-fluorouracil. Started Apr 2015; status: recruiting.
02
Drugs
fluorouracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR-IPR-15006431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006431.